Overcoming Challenges in Infectious Diseases
Discover the latest medical research on the prevention, management and treatment of infectious diseases.
LATEST TOPICS
-
New biomarkers for hypervirulent Klebsiella pneumoniae causing life-threatening complications in healthy individuals26 October, 2018A team of researchers led by Professor Thomas Russo from the University at Buffalo Jacobs School of Medicine and Biomedical Sciences have discovered several biomarkers that can accurately... -
Sequential doxycycline-sitafloxacin regimen for the treatment of Mycoplasma genitalium infections18 October, 2018Initial treatment with doxycycline for non-gonococcal urethritis (NGU) caused by Mycoplasma genitalium followed by resistance-guided therapy of sitafloxacin has been shown to be effective for... -
Levofloxacin resolves Stenotrophomonas maltophilia pneumonia12 October, 2018Antibiotic treatment with levofloxacin (500 mg/day) is shown to be effective in resolving persistent productive cough in a patient with Stenotrophomonas maltophilia pneumonia. A 61-year-old... -
Intravenous piperacillin-tazobactam and levofloxacin for Kocuria kristinae bacteraemic empyema4 October, 2018This is the first reported case of community-acquired Kocuria kristinae bacteraemic empyema – resolved after insertion of a chest tube and intravenous piperacillin-tazobactam and... -
Paraguay attains malaria-free status25 September, 2018The World Health Organization (WHO) certified Paraguay malaria-free on 11 June 2018, making it the first country in the Americas since Cuba in 1973, and the first among the E-2020 countries to... -
Oral levofloxacin and sitafloxacin are effective for the treatment of epididymitis19 September, 2018Pharmacokinetics study on oral levofloxacin (500 mg) and sitafloxacin (100 mg) conducted at the Okoyama University Hospital and its related institutions in Japan demonstrated efficacy for the... -
Levofloxacin: One of the most effective antibiotic for empiric therapy of dacryocystitis13 September, 2018Sensitivity data from a retrospective study investigating the microbiologic profile and antibiogram of patients with acute and chronic dacryocystitis demonstrated levofloxacin as one of the most... -
Secondary switch to oral levofloxacin allowed early rehabilitation in primary ventriculitis caused by Neisseria meningitidis6 September, 2018A four-week antibiotic regimen combining two weeks of intravenous cefotaxime followed by two weeks of oral levofloxacin was shown to be effective in the treatment of meningococcal ventriculitis... -
Long-term levofloxacin demonstrates safety for multidrug-resistant tuberculosis treatment in children29 August, 2018Long-term levofloxacin treatment has demonstrated safety and shown to be well-tolerated in a cohort of seventy children below 15 years of age with multidrug-resistant tuberculosis (MDR-TB). This... -
Prophylactic oral levofloxacin for febrile neutropaenia in acute myeloid leukaemia patients reduces hospital readmissions23 August, 2018Prophylactic oral levofloxacin is shown to be effective for febrile neutropaenia – thereby preventing hospital readmissions in patients with acute myeloid leukaemia (AML) after consolidation...
CONTENT LIBRARY
CONTENT LIBRARY
INTERVIEWS
-
Levofloxacin for the Management of Hospital-Acquired, Ventilator-Associated and Healthcare-Associated Pneumonia (Interview with Prof. Marin H. Kollef) -
The Use of Levofloxacin for the Treatment of Acute Exacerbation of Chronic Bronchitis (Interview with Prof. Hartmut Lode) -
Effect of Combination of Levofloxacin and Meropenem against Pseudomonas aeruginosa (Supervised by Prof. Kazuhiro Tateda, MD, PhD) -
Viewing Infectious Respiratory Disease (Supervised by Prof. Jiro Fujita, MD, PhD, ACCP) -
New Challenges for Levofloxacin in the Fight Against Infectious Diseases (Interviews with World-Renowned Experts) -
New Era for the Treatment of Respiratory Tract infections (Daiichi Pharmaceutical Co., Ltd., Special Interview) -
The Efficacy, Tolerability, and Benefits of 750 mg Once-Daily Levofloxacin in the Treatment of Community-Acquired Pneumonia (Interview with Prof. Thomas M. File, Jr, MD, MS ) -
Smarter Therapy: Guidelines for Optimal Management of Neutropenic Cancer Patients (Interview with Professor Thomas M. File, Jr.) -
Levofloxacin in the Medical Management of Community-acquired Pneumonia (Interview with Prof. Andy I. M. Hoepelman) -
The Way Forward: High-Dose, Short-Course Levofloxacin Leads the Field
UPCOMING EVENTS
21 November - 23 November, 2018
Saint Julian, Malta, Western Europe
26 November - 28 November, 2018
Liverpoo, UK, Western Europe
29 November - 02 December, 2018
Taipei, Taiwan, Asia Pacific
